[1]
M. A. Sahin, “Cilostazol, a Type III Phosphodiesterase Inhibitor, Reduces Ischemia/Reperfusion-Induced Spinal Cord Injury”, HSF, vol. 14, no. 3, pp. E171-E177, Jun. 2011.